Chronic Kidney Disease Drugs Market Size, Share & Industry Analysis, By Drug Class (SGLT2 Inhibitors, ACE Inhibitors, Angiotensin II Receptor Blockers, Direct Renin Inhibitors, Mineralocorticoid Receptor Antagonists, Endothelin Receptor Antagonists, & Others), By Stage (Stage 1, Stage 2, Stage 3a, Stage 3b, Stage 4, & Others), By Disease Indication (Diabetic Kidney Disease, Hypertensive Nephropathy / Nephrosclerosis, Polycystic Kidney Disease, Chronic Tubulointerstitial Nephritis, & Others), By Route of Administration, By Distribution Channel, and Regional Forecast, 2026-2034